Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report
Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report. // Medical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2949918626001038?dgcid=rss_sd_all
Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report. Medical Reports. https://www.sciencedirect.com/science/article/pii/S2949918626001038?dgcid=rss_sd_all
“Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report.” Medical Reports.
@article{article104312,
title = {Savolitinib plus cetuximab in recurrent/metastatic head and neck squamous cell carcinoma with EGFR and MET amplification after cetuximab-based therapy: A case report},
journal = {Medical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2949918626001038?dgcid=rss_sd_all}
}